Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Beiersdorf Unveils Breakthrough Anti-Glycation Ingredient to Combat Sugar-Induced Skin Aging

(IN BRIEF) After nearly a decade of research, Beiersdorf has revealed a groundbreaking discovery in skincare: a patented active ingredient called NAHP, also known as GLYCOSTOP™, designed to counteract the skin’s glycation process induced by sugar consumption, which contributes to … Read the full press release

Neste Successfully Converts Discarded Tires into High-Quality Raw Material for Chemicals and Plastics

(IN BRIEF) Neste has achieved a significant milestone in chemical recycling by processing pyrolysis oil derived from discarded vehicle tires, supplied by Scandinavian Enviro Systems, into high-quality raw material for new plastics and chemicals at its refinery in Porvoo, Finland. … Read the full press release

DNV Bolsters Presence in Aquaculture Sector with Full Ownership of Ocean Ecology

(IN BRIEF) DNV has completed the acquisition of Ocean Ecology, a leading UK marine environmental consultancy, solidifying its position in the aquaculture and biodiversity sector. Previously majority-owned by Åkerblå, Ocean Ecology has established itself as a trusted provider of marine … Read the full press release

Swissloop Tunneling Triumphs at Not-a-Boring Competition 2024 with Groundhog Beta

(IN BRIEF) Swissloop Tunneling, a team of students from ETH Zurich supported by Empa, emerged victorious at the Not-a-Boring Competition 2024 in Bastrop, Texas, with their innovative micro-tunneling machine, Groundhog Beta. The team’s success marks a significant milestone in the … Read the full press release

Philips Museum Launches Interactive AI Exhibition: brAInpower

(IN BRIEF) The Philips Museum in Eindhoven, Netherlands, is set to unveil its new exhibition, ‘brAInpower,’ on April 20th, focusing on artificial intelligence (AI) and its impact, particularly in healthcare. Through interactive elements, rare collection pieces, and informative videos, visitors … Read the full press release

Modern Weather Models Revolutionize Satellite Movement Predictions

(IN BRIEF) Researchers at the Institute for Atmospheric and Earth System Research (INAR) at the University of Helsinki have discovered that modern weather models accurately predict the energy emitted and reflected by the Earth, affecting the movements of low Earth-orbiting … Read the full press release

Advancements in Causal Machine Learning Poised to Revolutionize Medical Diagnostics and Therapy, Researchers Say

(IN BRIEF) An international research group, led by Professor Stefan Feuerriegel from LMU, is pioneering the application of causal machine learning (ML) in medical diagnostics and therapy. Published in Nature Medicine, their study asserts that causal ML has the potential … Read the full press release

University of Liverpool Awarded £1.3m to Combat Antimicrobial Resistance in Fleming Fund Partner Countries

(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release

Sanofi’s Frexalimab Shows Promise in Phase 2 for Treating Multiple Sclerosis

(IN BRIEF) Sanofi’s experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis (MS). Presented at the American Academy of Neurology Annual Meeting, the data reveals sustained reduction in disease activity and favorable … Read the full press release

Evotec Appoints Aurélie Dalbiez as Chief People Officer to Drive Organizational Excellence

(IN BRIEF) Evotec SE announces the appointment of Aurélie Dalbiez as their new Chief People Officer (CPO), effective June 15, 2024. Joining the Management Board, Aurélie brings over 25 years of international Human Resources leadership experience, previously serving as the … Read the full press release

Long-Term Study Shows Sustained Efficacy of Kesimpta in Treating Relapsing Multiple Sclerosis

(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in treating relapsing multiple sclerosis (RMS) over a span of up to six years. The study, presented at the American Academy … Read the full press release

AstraZeneca’s IMPACT CKD Model Forecasts Alarming Rise in Chronic Kidney Disease by 2032

(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release

Unveiling Genetic Responses: Study Illuminates Boron Deficiency Impact on Oilseed Rape Plants

(IN BRIEF) A collaborative study involving researchers from the Technical University of Munich, Bielefeld University, and the Leibniz Institute of Plant Genetics and Crop Plant Research sheds light on the genetic mechanisms underlying the detrimental effects of boron deficiency on … Read the full press release

Dr. Ivano Malavolta Receives Dutch ICT Research Prize 2024 for Advancing Energy-Efficient Robotics Software

(IN BRIEF) Dr. Ivano Malavolta, associate professor at Vrije Universiteit Amsterdam, has been awarded the prestigious Dutch Prize for ICT Research 2024 for his groundbreaking work in energy-efficient robotics software. Presented during NWO ICT.OPEN2024 by Professor Ad Ijzerman and Professor … Read the full press release

Advancing Healthcare: Bosch and Randox Labs Partner to Revolutionize Molecular Diagnostics

(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release

EBRD Invests €22 Million to Propel Farmak’s Expansion into Polish Market

(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant Farmak Group to facilitate its strategic acquisition of a Polish pharmaceutical company and to upgrade its IT systems. Farmak, a … Read the full press release

Study Reveals High Rates of Repeat Antibiotic Prescriptions for Respiratory Tract Infections in UK Primary Care

(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University Medical Center Utrecht highlights the concerning prevalence of repeat antibiotic prescriptions for respiratory tract infections (RTIs) within the same episode … Read the full press release

Infant Brain Responses to Speech Predict Later Language Development, Study Finds

(IN BRIEF) A study conducted at the University of Helsinki under the DyslexiaBaby project reveals that infants’ neural responses to speech sounds can predict their later development of language and literacy skills. Stronger neural responses in the left side of … Read the full press release

Breakthrough Study: Single Genetic Test Offers Early Diagnosis for Children with Rare Disorders

(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University of Cambridge introduces a novel approach to genetic testing, potentially revolutionizing the diagnosis of rare developmental disorders in children. By … Read the full press release

WACKER and Pantherna Collaborate to Ramp Up mRNA Production for ARDS Treatment

(IN BRIEF) WACKER’s mRNA competence center in Halle is gearing up to produce an active ingredient for combatting acute respiratory distress syndrome (ARDS) in collaboration with Pantherna Therapeutics. The center, equipped with four new production lines, will more than triple … Read the full press release

AstraZeneca’s Imfinzi Shows Promising Results in Phase III Trial for Small Cell Lung Cancer

(IN BRIEF) AstraZeneca announces positive outcomes from the ADRIATIC Phase III trial, revealing that its immunotherapy drug Imfinzi (durvalumab) demonstrated a significant improvement in overall survival (OS) and progression-free survival (PFS) among patients with limited-stage small cell lung cancer (LS-SCLC) … Read the full press release

University of Helsinki Study Uncovers Pre-Industrial Atmosphere Insights from Finnish Peatland

(IN BRIEF) Researchers at the University of Helsinki’s Institute for Atmospheric and Earth System Research (INAR) conducted a study in Finland’s Siikaneva peatland, revealing significant insights into pre-industrial aerosol formation processes. The investigation highlighted the release of highly oxygenated organic … Read the full press release

FDA Approves Basilea’s ZEVTERA® for Severe Bacterial Infections, Including Pediatric Use

(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (ceftobiprole medocaril sodium for injection). The approval covers its use in adult patients with Staphylococcus aureus bloodstream infections (bacteremia), … Read the full press release

Three Mushketeers: Transforming Mushroom Surplus into Culinary Gold

(IN BRIEF) Three Mushketeers, a startup founded by Emmi Korjus, Emma Kynkäniemi, and Ida Nikkilä, is revolutionizing the use of surplus mushrooms by creating a mushroom powder that enhances the taste of vegetarian dishes. The powder, currently in its second … Read the full press release

Unitaid Grants Additional Funding to University of Liverpool-led LONGEVITY Project for Long-Acting Infectious Disease Therapeutics

(IN BRIEF) Unitaid has allocated over £6 million in new funding to the University of Liverpool-led LONGEVITY project, aimed at enhancing long-acting therapeutics for tuberculosis, malaria, and hepatitis C. Started in 2020, the project has achieved preclinical milestones for long-acting … Read the full press release

University of Helsinki Launches Doctoral Researcher Positions Pilot Funded by Finnish Ministry

(IN BRIEF) The University of Helsinki has initiated a doctoral education pilot, sponsored by the Finnish Ministry of Education and Culture, offering three-year positions for doctoral researchers. With 236 vacancies across 11 sectoral pilots, the application period runs until April … Read the full press release

AstraZeneca and Daiichi Sankyo’s BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been acknowledged by the US FDA for treating adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received prior systemic … Read the full press release

Navigating the Complexities of Big Data: Insights and Concerns Explored

(IN BRIEF) The realm of scientific research is experiencing a revolution with the advent of Big Data, allowing for the extraction of valuable insights and patterns from vast datasets. Xiaoyao Han, a PhD student at UG/Campus Fryslân, delves into the … Read the full press release

AstraZeneca and Sanofi’s Beyfortus Receives Approval in Japan for Prophylaxis against Respiratory Syncytial Virus

(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release

AstraZeneca’s Truqap Gets Green Light in Japan for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca announces the approval of Truqap (capivasertib) in combination with Faslodex (fulvestrant) by the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating adult patients with unresectable or recurrent hormone receptor-positive, HER2-negative breast cancer. The approval, based … Read the full press release

Sony Study Reveals Persisting Mental Health Challenges Among European Surgeons and Oncologists

(IN BRIEF) A recent survey conducted by Sony Healthcare Europe indicates that 95% of surgeons and oncologists across Europe experienced negative mental health issues in 2023, a level comparable to the aftermath of the pandemic in 2021. The survey of … Read the full press release

Merck Expands M LabTM Collaboration Center in Shanghai, Enhancing Biopharmaceutical Capabilities

(IN BRIEF) Merck, a prominent science and technology company, announces a €14 million expansion of its M LabTM Collaboration Center in Shanghai, bolstering its support for the biopharmaceutical industry in China. The expansion includes new facilities such as a biology … Read the full press release

Study Reveals Higher Prevalence of Lewy Body Disease in Middle-Aged Population

(IN BRIEF) A recent study by the University of Helsinki and the University of Tampere suggests that Lewy body disease, the second most common brain degenerative disorder after Alzheimer’s, may be more prevalent in middle-aged individuals than previously believed. Utilizing … Read the full press release

Fraunhofer Showcases AI-Based Healthcare Innovations at DMEA 2024

(IN BRIEF) Fraunhofer experts are at the forefront of developing AI-driven systems to revolutionize healthcare, presenting their latest advancements at the DMEA 2024 trade show. These innovations span various areas, including diagnostics, surgery planning, telemedicine, and data management. From AI-based … Read the full press release

Mubadala Acquires KELIX bio, Expanding Access to Life-Saving Pharmaceuticals in Emerging Markets

(IN BRIEF) DPI, BII, and the EBRD have reached a binding agreement to fully exit their investment in KELIX bio, a pan-African biopharmaceutical platform, through its acquisition by Mubadala Investment Company. Founded in 2020, KELIX bio has rapidly grown to … Read the full press release

Novo Nordisk Acquires Cardior Pharmaceuticals in Billion-Euro Deal, Pioneering RNA Therapies for Heart Diseases

(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release

Ultomiris Receives FDA Approval as First Long-Acting Treatment for AQP4 Ab+ NMOSD, Redefining Patient Care

(IN BRIEF) Ultomiris (ravulizumab-cwvz) has gained approval from the FDA as the inaugural long-acting C5 complement inhibitor for treating adult patients with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD). The approval, based on the CHAMPION-NMOSD Phase III trial’s … Read the full press release

Annual Charity Netball Tournament Raises Over £32,000 for Look Good Feel Better Cancer Support Charity

(IN BRIEF) Look Good Feel Better, in partnership with England Netball, organized its Annual Charity Netball Tournament at the University of Warwick, raising over £32,000 for individuals undergoing cancer treatment. The event, attended by 240 netball players, featured 26 teams … Read the full press release

Breakthrough Blood Test May Revolutionize Tuberculosis Detection, Potentially Saving Millions of Lives

(IN BRIEF) Researchers at the University of Southampton have made significant progress towards developing a blood test capable of identifying millions of individuals unknowingly spreading tuberculosis (TB). By analyzing blood markers, the study identified a set of six proteins highly … Read the full press release

Understanding Women’s Sleep and Emotions Across the Menstrual Cycle: New Research Insights

(IN BRIEF) New research reveals that women experience disruptions in sleep patterns and heightened feelings of anger in the days leading up to their period, shedding light on the intricate relationship between menstrual cycles, emotions, and sleep. Conducted by the … Read the full press release